Osteoporosis (OP) is a systemic disease susceptible to fracture due to the decline of bone
mineral density and bone mass, the destruction of bone tissue microstructure, and increased …

Background: With society aging, the rising prevalence of osteoporosis (OP) has enormous
social and economic implications. At present, the Zhibai Dihuang pill has been clinically …

Background Osteoporosis (OP) and type 2 diabetes (T2D) are commonly encountered
metabolic disorders in clinical practice, but the comorbidity mechanism has not been …

In this study, the network pharmacology analysis method was used to explore the bioactive
components and targets of Xianlinggubao (XLGB) and further elucidate its potential …

Objective To explore the differential expression and mechanisms of bone formation-related
genes in osteoporosis (OP) leveraging bioinformatics and machine learning methodologies …

Background Xianlinggubao capsule (XLGB), a traditional Chinese medicine (TCM)
prescription, has been widely applied to treat osteoporosis (OP) in China. However, its …

Postmenopausal osteoporosis (PMOP) has became 1 of most prevalent bone disorders with
aging population. Liuwei Dihuang (LWDH) Pill, a classical kidney-tonifying prescription, is …

Osteoporosis is a serious threat to human life. Guben Zenggu Granule is an empirical
prescription for clinical treatment of osteoporosis. MC3T3-E1 cells are mouse osteogenic …

Postmenopausal osteoporosis (PMOP) is an important part of primary osteoporosis, and the
current clinical treatment program for PMOP is easily limited by side effects and adverse …

Whether ursolic acid is an effective drug in treatment of osteoporosis (OP) and how it exhibit
activity effect on OP is unclear. To investigated the potential molecular mechanism of ursolic …